入院时SpO2与ROX指数预测COVID-19患者结局
本回顾性观察研究纳入72例COVID-19危重患者,在入院6小时内于室内空气下测定SpO2和呼吸频率,计算简化ROX指数(SpO2/RR)。SpO2预测任何机械通气需求的AUC为0.9(95%CI 0.8-0.96),切点≤78%时敏感度70%、特异度100%、阳性预测值100%。MV组中NIV成功37例(74%),需气管插管13例(26%);ROX≤1.4预测早期NIV失败的敏感度85%、特异度86%、AUC 0.86(95%CI 0.73-0.94)。
要点
- 入院6小时内室内空气SpO2≤78%对需机械通气预测特异度100%、阳性预测值100%,AUC 0.9(95%CI 0.8-0.96)。
- 简化ROX指数=室内空气SpO2/呼吸频率,入院6小时内ROX≤1.4预测早期NIV失败,敏感度85%、特异度86%。
- MV组中NIV成功37例(74%),需气管插管13例(26%),ROX≤1.4者应警惕NIV失败。
- SpO2、CT评分和ROX指数均用AUC评估预测需MV的准确性,其中SpO2切点≤78%。
适用人群与场景
- COVID-19阳性危重患者,ICU入院时纳入,入院6小时内于室内空气下测定SpO2和呼吸频率。
诊断标准与关键阈值
- 室内空气SpO2≤78%为预测需任何机械通气(有创或无创)的切点,敏感度70%、特异度100%、阳性预测值100%。
- 简化ROX指数=SpO2/呼吸频率,切点≤1.4预测早期NIV失败,敏感度85%、特异度86%。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 室内空气SpO2≤78%提示需机械通气风险高(特异度100%、阳性预测值100%),应评估机械通气需求。
- ROX≤1.4提示早期NIV失败风险高(敏感度85%、特异度86%),需密切监测并准备气管插管。
研究设计与关键结果
- 回顾性观察研究,纳入72例COVID-19危重患者,入住ICU,入院6小时内室内空气下测SpO2和RR。
- SpO2预测任何机械通气需求的AUC 0.9(95%CI 0.8-0.96),切点≤78%,敏感度70%、特异度100%、P<0.001。
- MV组中NIV成功37例(74%),需气管插管13例(26%)。
- ROX≤1.4预测早期NIV失败:敏感度85%、特异度86%、AUC 0.86(95%CI 0.73-0.94),P<0.0001。
证据类型、等级与局限
- 回顾性观察研究,单中心,样本量72例,未提及盲法与样本量计算,结果需前瞻性验证。
对床旁实践的改变
- 对COVID-19危重患者入院6小时内室内空气下计算SpO2和简化ROX指数,SpO2≤78%提示需机械通气风险高,ROX≤1.4提示NIV失败风险高,应加强监测并准备插管。
- 原文未提及适用与不适用人群的排除标准,使用切点时需结合临床。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to evaluate the accuracy of pulse oximetry-derived oxygen saturation (SpO2) on room air, determined at hospital admission, as a predictor for the need for mechanical ventilatory support in patients with Coronavirus Disease-2019 (COVID-19).
METHODS: In this retrospective observational study, demographic and clinical details of the patients were obtained during ICU admission. SpO2 and respiratory rate (RR) on room air were determined within the first 6 h of hospital admission. As all measurements were obtained on room air, we calculated the simplified respiratory rate‑oxygenation (ROX) index by dividing the SpO2 by the RR. Based on the use of any assistance of mechanical ventilator (invasive or noninvasive), patients were divided into mechanical ventilation (MV) group and oxygen therapy group. The accuracy of the SpO2, CT score, and ROX index to predict the need to MV were determined using the Area under receiver operating curve (AUC).
RESULTS: We included 72 critically ill patients who tested COVID-19-positive. SpO2 on the room air could predict any MV requirement (AUC [95% confidence interval]: 0.9 [0.8-0.96], sensitivity: 70%, specificity 100%, cut-off value ≤78%, P < 0.001). Within the MV group, the use of noninvasive ventilation (NIV) was successful in 37 (74%) patients, whereas 13 patients (26%) required endotracheal intubation. The cut-off ROX value for predicting early NIV failure was ≤1.4, with a sensitivity of 85%, a specificity of 86%, and an AUC of 0.86 (95% confidence interval of 0.73-0.94, P < 0.0001).
CONCLUSIONS: A baseline SpO2 ≤78% is an excellent predictor of MV requirement with a positive predictive value of 100%. Moreover, the ROX index measured within the first 6 h of hospital admission is a good indicator of early NIV failure.
参考来源
- Mukhtar A, Rady A, Hasanin A, et al. Admission SpO2 and ROX index predict outcome in patients with COVID-19. Am J Emerg Med. 2021. PMID: 34332217. doi:10.1016/j.ajem.2021.07.049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。